How to read a dose.
Doses come in milligrams or micrograms. Your syringe measures volume. Concentration is the bridge between them.
- 1 mg = 1,000 mcg. Mixing the two up is a thousandfold mistake.
- Concentration is the vial's milligrams divided by the water's millilitres.
- On a U-100 syringe, 1 unit is 0.01 mL, so 100 units fill 1 mL. Read the printed numbers, not the tick count.
- Approved drug labels start low and step up. Zepbound starts at 2.5 mg weekly, and each dose lasts at least 4 weeks.
- Cycles like five days on, two off are reported by users. No study shows the breaks prevent tolerance or side effects.
The math, worked once
This lesson does not set a safe dose for BPC-157 or anything else. It shows the arithmetic, which works the same for any powder vial.
The setup: a vial holding 5 mg, mixed with exactly 1 mL of water as in lesson 5. The amount to measure is 250 mcg.
Your numbers depend on the water you actually added. Same vial with 2 mL of water: half the strength, so the same amount is twice the units.
250 mcg is a BPC-157 amount users report, not a recommendation. BPC-157 is not approved, and its under-skin schedules lack published dose and safety results.
How labels and trials step doses up
- Wegovy 0.25 mg weekly, rising every 4 weeks to 2.4 mg.
- Zepbound 2.5 mg weekly, rising in 2.5 mg steps up to 15 mg.
- Retatrutide A phase 2 group went 2, 4, 8, then 12 mg weekly, four weeks apart.
Increase only when needed and tolerated. If a step isn't tolerated, the Wegovy label allows delaying the next one for 4 weeks.
Past the research
If people report a dose higher than anything tested in humans, the peptide's page says "Above anything studied in humans". That maximum isn't a safe limit. It's just where the research stops.
Next: Lesson 7: Side effects
Information only, not medical advice. Peptifacts does not sell anything and does not link to sellers.